Adhera Therapeutics, Inc. (ATRX) Research

Adhera Therapeutics, Inc., headquartered in Baton Rouge, Louisiana, is primarily focused on the identification and development of new pharmaceutical compounds. The company officially adopted its current name in October 2018, having previously operated under the designation Marina Biotech, Inc.

Market snapshot

Symbol
ATRX
Price
$0.00
Day change
0.00%
Market cap
$722.0
P/E ratio
-0.00x
52-week range
0.0001-0.01
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Calithera Biosciences, Inc. (CALA)
  • CannAmerica Brands Corp. (CNNXF)
  • eFFECTOR Therapeutics, Inc. (EFTR)
  • GlobeImmune, Inc. (GBIM)
  • IMRIS Inc. (IMRSQ)
  • IMV Inc. (IMVIF)
  • Motus GI Holdings, Inc. (MOTS)
  • OncoSec Medical Incorporated (ONCSQ)

Recent insider activity

  • Waerness Trond Kydd — trade (0 shares) on 2021-04-20
  • Subhan Zahed — trade (0 shares) on 2021-11-05
  • KUCHARCHUK ANDREW ALBERT — trade (0 shares) on 2020-07-07
  • Stanley Rhonda L. — A-Award (350000 shares) on 2019-11-01
  • Stanley Rhonda L. — trade (0 shares) on 2019-11-01

Open Adhera Therapeutics, Inc. (ATRX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.